4Society of Thoracic Surgeons Blood Conservation Guideline Task Force,Ferraris VA,Ferraris SP,et al.Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery:The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline[J].Ann Thorac Surg,2007,83:S27-86. 被引量：1
5Andrew M,Paes B,Johnston M.Development of the hemostatic system in the neonate and young infant[J].Am J Pediatr Hematol Oncol,1990,12(1):95-104. 被引量：1
6Kettner SC,Pollak A,Zimpfer M,et al.Heparinase-Modified Thrombelastography in Term and Preterm Neonates[J].Anesth Analg,2004,98(6):1650-1652. 被引量：1
7Haizinger B,Gombotz H,Rehak P,et al.Activated thrombelastogram in neonates and infants with complex congenital heart disease in comparison with healthy children[J].Br J Anaesth.,2006,97(4):545-552. 被引量：1
8Miller BE,Guzzetta NA,Tosone SR,et al.Tissue factor-activated thromboelastograms in children undergoing cardiac surgery:baseline values and comparisons[J].Anesth Analg,2003,97(5):1289-1293. 被引量：1
9Miller BE,Williams GD.Bleeding and coagulation:monitoring and management[A].(In) Dean B.Andropoulos,Gary's anesthesia book[M].First edition.USA:Publisher,2004.157-172. 被引量：1
10Gill JC,Wilson AD,Endres-Brooks J,et al.Loss of largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects[J].Blood,1986,67(3):758-761. 被引量：1
